Article Information
History
- March 18, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Carmen S Arriola1,*,
- Giselle Soto2,
- Matthew Westercamp3,
- Susan Bollinger3,
- Angelica Espinoza2,
- Max Grogl2,
- Alejandro Llanos-Cuentas4,
- Eduardo Matos5,
- Candice Romero2,
- Maria Silva2,
- Rachel Smith3,
- Natalie Olson1,
- Michael Prouty2,
- Eduardo Azziz-Baumgartner1 and
- Fernanda C. Lessa3
- 1Centers for Disease Control and Prevention, Influenza Division, National Center for Immunization and Respiratory Diseases (NCIRD), Atlanta, Georgia, USA
- 2Naval Medical Research Unit No 6 (NAMRU-6), Lima, Peru
- 3Centers for Disease Control and Prevention, Division of Healthcare Quality and Promotion, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Atlanta, Georgia, USA
- 4Cayetano Heredia Hospital, Lima, Peru
- 5Arzobispo Loayza National Hospital, Lima, Peru
- ↵*Corresponding Author: Carmen Sofia Arriola, Influenza Division, Centers for Disease Control and Prevention, 1600 Clifton Rd MS A-32, Atlanta, GA 30329, United States; telephone: (404) 718-4589; fax (404) 639-3866; email: wus3{at}cdc.gov.
Posted March 18, 2022.
“Effectiveness of whole virus COVID-19 vaccine at protecting health care personnel against SARS-CoV-2 infections in Lima, Peru”
